annual CFO:
-$194.50M-$91.67M(-89.16%)Summary
- As of today (June 28, 2025), KYMR annual cash flow from operations is -$194.50 million, with the most recent change of -$91.67 million (-89.16%) on December 31, 2024.
- During the last 3 years, KYMR annual CFO has fallen by -$65.56 million (-50.84%).
- KYMR annual CFO is now -320.70% below its all-time high of $88.13 million, reached on December 31, 2020.
Performance
KYMR Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$79.15M-$17.37M(-28.11%)Summary
- As of today (June 28, 2025), KYMR quarterly cash flow from operations is -$79.15 million, with the most recent change of -$17.37 million (-28.11%) on March 31, 2025.
- Over the past year, KYMR quarterly CFO has dropped by -$39.56 million (-99.92%).
- KYMR quarterly CFO is now -160.11% below its all-time high of $131.67 million, reached on September 30, 2020.
Performance
KYMR quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$234.06M-$39.56M(-20.34%)Summary
- As of today (June 28, 2025), KYMR TTM cash flow from operations is -$234.06 million, with the most recent change of -$39.56 million (-20.34%) on March 31, 2025.
- Over the past year, KYMR TTM CFO has dropped by -$135.61 million (-137.75%).
- KYMR TTM CFO is now -316.33% below its all-time high of $108.20 million, reached on September 30, 2020.
Performance
KYMR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KYMR Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.2% | -99.9% | -137.8% |
| 3 y3 years | -50.8% | -96.4% | -59.9% |
| 5 y5 years | -1186.3% | -556.5% | -1841.3% |
KYMR Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.2% | at low | -1083.8% | at low | -137.8% | at low |
| 5 y | 5-year | -320.7% | at low | -160.1% | at low | -316.3% | at low |
| alltime | all time | -320.7% | at low | -160.1% | at low | -316.3% | at low |
KYMR Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$79.15M(+28.1%) | -$234.06M(+20.3%) |
| Dec 2024 | -$194.50M(+89.2%) | -$61.78M(+23.1%) | -$194.50M(+56.0%) |
| Sep 2024 | - | -$50.19M(+16.9%) | -$124.67M(+17.5%) |
| Jun 2024 | - | -$42.94M(+8.4%) | -$106.13M(+7.8%) |
| Mar 2024 | - | -$39.59M(-592.1%) | -$98.45M(-4.3%) |
| Dec 2023 | -$102.83M(-32.8%) | $8.04M(-125.4%) | -$102.83M(-31.6%) |
| Sep 2023 | - | -$31.65M(-10.2%) | -$150.41M(-1.7%) |
| Jun 2023 | - | -$35.26M(-19.8%) | -$153.03M(-2.4%) |
| Mar 2023 | - | -$43.97M(+11.2%) | -$156.76M(+2.4%) |
| Dec 2022 | -$153.09M | -$39.54M(+15.4%) | -$153.09M(+0.8%) |
| Sep 2022 | - | -$34.27M(-12.1%) | -$151.90M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$38.98M(-3.3%) | -$154.89M(+5.8%) |
| Mar 2022 | - | -$40.30M(+5.1%) | -$146.42M(+13.5%) |
| Dec 2021 | -$128.95M(-246.3%) | -$38.35M(+2.9%) | -$128.95M(+16.5%) |
| Sep 2021 | - | -$37.26M(+22.1%) | -$110.66M(-289.9%) |
| Jun 2021 | - | -$30.51M(+33.7%) | $58.27M(-24.7%) |
| Mar 2021 | - | -$22.82M(+13.7%) | $77.36M(-12.2%) |
| Dec 2020 | $88.13M(+392.2%) | -$20.07M(-115.2%) | $88.13M(-18.5%) |
| Sep 2020 | - | $131.67M(-1253.8%) | $108.20M(-561.0%) |
| Jun 2020 | - | -$11.41M(-5.3%) | -$23.47M(+94.7%) |
| Mar 2020 | - | -$12.06M | -$12.06M |
| Dec 2019 | $17.91M(-200.2%) | - | - |
| Dec 2018 | -$17.86M | - | - |
FAQ
- What is Kymera Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Kymera Therapeutics?
- What is Kymera Therapeutics annual CFO year-on-year change?
- What is Kymera Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly CFO year-on-year change?
- What is Kymera Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Kymera Therapeutics?
- What is Kymera Therapeutics TTM CFO year-on-year change?
What is Kymera Therapeutics annual cash flow from operations?
The current annual CFO of KYMR is -$194.50M
What is the all time high annual CFO for Kymera Therapeutics?
Kymera Therapeutics all-time high annual cash flow from operations is $88.13M
What is Kymera Therapeutics annual CFO year-on-year change?
Over the past year, KYMR annual cash flow from operations has changed by -$91.67M (-89.16%)
What is Kymera Therapeutics quarterly cash flow from operations?
The current quarterly CFO of KYMR is -$79.15M
What is the all time high quarterly CFO for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly cash flow from operations is $131.67M
What is Kymera Therapeutics quarterly CFO year-on-year change?
Over the past year, KYMR quarterly cash flow from operations has changed by -$39.56M (-99.92%)
What is Kymera Therapeutics TTM cash flow from operations?
The current TTM CFO of KYMR is -$234.06M
What is the all time high TTM CFO for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM cash flow from operations is $108.20M
What is Kymera Therapeutics TTM CFO year-on-year change?
Over the past year, KYMR TTM cash flow from operations has changed by -$135.61M (-137.75%)